Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi


  • Niharika SwainEmail author
  • Rashmi Maruti Hosalkar
  • Samapika Routray
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_102002


Historical Background

Syndecans, a cell surface heparin sulfate proteoglycan family, are generally expressed on the surface of all adherent cells and many nonadherent cells. Based on its function as an anchor that stabilizes epithelial sheet morphology by connecting the extra cellular matrix (ECM) to intracellular cytoskeleton, this family of proteoglycans was termed as “syndecan,” derived from Greek word “syndein” meaning to bind together. They consist of four members: syndecan-1, syndecan-2 (fibroglycan), syndecan-3(N-syndecan), and syndecan-4 (amphiglycan/ryudocan) each encoded by a distinct gene (Teng et al. 2011). In 1989, Merton Bernfield’s group cloned the first member, syndecan-1, followed by identification of other members in the following years. It soon became apparent that they could support cell adhesion, and now it is known that...

This is a preview of subscription content, log in to check access.


  1. Couchman JR, Gopal S, Lim HC, Nørgaard S, Multhaupt HA. Syndecans: from peripheral co-receptors to mainstream regulators of cell behaviour. Int J Exp Pathol. 2015;96(1):1–10.  https://doi.org/10.1111/iep.12112.CrossRefPubMedPubMedCentralGoogle Scholar
  2. David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development. 1993;119(3):841–54.PubMedPubMedCentralGoogle Scholar
  3. Elenius K, Jalkanen M. Function of the syndecans – a family of cell surface proteoglycans. J Cell Sci. 1994;107(Pt 11):2975–82.Google Scholar
  4. Gharbaran R. Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies. Crit Rev Oncol Hematol. 2015;94(1):1–17.  https://doi.org/10.1016/j.critrevonc.2014.12.003.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Juuti A, Nordling S, Lundin J, Louhimo J, Haglund C. Syndecan-1 expression – a novel prognostic marker in pancreatic cancer. Oncology. 2005;68(2-3):97–106.  https://doi.org/10.1159/000085702. Epub 2005 May 9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Kiviniemi J, Kallajoki M, Kujala I, Matikainen MT, Alanen K, Jalkanen M, Salmivirta M. Altered expression of syndecan-1 in prostate cancer. APMIS. 2004;112(2):89–97.  https://doi.org/10.1111/j.1600-0463.2004.apm1120202.x.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Kopper L, Sebestyén A, Gallai M, Kovalszky I. Syndecan-1 – a new piece in B-cell puzzle. Pathol Oncol Res. 1997;3(3):183–91.  https://doi.org/10.1007/BF02899919.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Kusumoto T, Kodama J, Seki N, Nakamura K, Hongo A, Hiramatsu Y. Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer. Oncol Rep. 2010;23(4):917–25.PubMedPubMedCentralGoogle Scholar
  9. Lendorf ME, Manon-Jensen T, Kronqvist P, Multhaupt HA, Couchman JR. Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma. J Histochem Cytochem. 2011;59(6):615–29.  https://doi.org/10.1369/0022155411405057.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Muramatsu T, Saitoh M, Ro Y, Uekusa T, Iwamura E, Ohta K, Kohno Y, Abiko Y, Shimono M. Inhibition of syndecan-1 expression and function in oral cancer cells. Oncol Rep. 2008;20(6):1353–7.PubMedPubMedCentralGoogle Scholar
  11. Sanderson RD, Lalor P, Bernfield MB. Lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1989;1(1):27–35.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Sebestyén A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. Br J Haematol. 1999;104(2):412–9.  https://doi.org/10.1046/j.1365-2141.1999.01211.x.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Szatmári T, Otovos R, Hjerpe A, Dobra K. Syndecan-1 in cancer: implications for cell signaling, differentiation, and prognostication. Dis Markers. 2015;2015:796052.  https://doi.org/10.1155/2015/796052.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Teng YH, Aguino RS, Park PW. Molecular functions of syndecan-1 in disease. Matrix Biol. 2011;31(1):3–16.  https://doi.org/10.1016/j.matbio.2011.10.001.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Niharika Swain
    • 1
    Email author
  • Rashmi Maruti Hosalkar
    • 2
    • 3
  • Samapika Routray
    • 4
  1. 1.MGM Dental College and HospitalNavi MumbaiIndia
  2. 2.Indian Association of Oral and Maxillofacial PathologistsMumbaiIndia
  3. 3.Maharashtra State Dental CouncilMumbai, MaharashtraIndia
  4. 4.Department of Dental SurgeryAll India Institute of Medical SciencesBhubaneswarIndia